Agios Pharmaceuticals (AGIO) Preferred Shares (2012 - 2013)

Agios Pharmaceuticals (AGIO) posted Preferred Shares of $5.7 million for Q3 2013, down 82.7% on a QoQ basis from $32.9 million in Q2 2013.

Agios Pharmaceuticals (AGIO) Preferred Shares (2012 - 2013) Analysis & Trends

Agios Pharmaceuticals' Preferred Shares history runs 2 years deep, the most recent figure standing at $5.7 million for Q3 2013.

Quarterly Preferred Shares changed N/A year-over-year to $5.7 million in Q3 2013, while the trailing twelve-month figure through Sep 2013 was $5.7 million (changed N/A YoY) and the FY2012 annual result came in at $32.9 million, changed N/A from the prior year.
Preferred Shares was $5.7 million for Q3 2013 at Agios Pharmaceuticals, down from $32.9 million in the prior quarter.
Across five years, Preferred Shares topped out at $32.9 million in Q4 2012 and bottomed at $5.7 million in Q3 2013.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Agios Pharmaceuticals	2.13 Bn	2.13 Bn	19.43 Mn	-

Download Data